Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is associated with a lower risk for dementia in older adults with mood and psychotic disorders, according to a study published online June 30 in JAMA Network Open.
Source: Medical Xpress
Lower dementia risk seen with sodium-glucose cotransporter 2 in seniors 65+ with mood, psychotic disorders
